MOTS-C × ramppeptides.com — lab test, August 2026
COA 2608030655 matches freedomdiagnosticstesting.com's public record. So this test doesn't rest on our review alone — the lab confirms it too.
Ramp2608030655Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 40 mg · Lab measured 40.89 mg
102% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 10.2 mg using the measured mass, against 10 mg on the label — 2% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | 2608030655 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 21 Aug 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | freedomdiagnosticstesting.com's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of MOTS-C from ramppeptides.com, performed by freedomdiagnosticstesting.com on August 4, 2026. Reported purity: 99.52%. Net content: 40.89 mg against 40 mg labeled (102% of label). Batch MOTSC40-RP02. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Other lots of MOTS-C from ramppeptides.com
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| MOTC10 RP03 | 17 Jul 2026 | freedomdiagnosticstesting.com | 99.93% | 116% | ✓ Lab-verified |
| MOTC10-RP02 | 29 Jun 2026 | freedomdiagnosticstesting.com | 99.46% | 115% | ✓ Lab-verified |
| MOTSC40-RP01 | 7 Jun 2026 | freedomdiagnosticstesting.com | 99.72% | 100% | ✓ Lab-verified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion